These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antidepressant treatment for depression: total charges and therapy duration*. Dobrez DG; Melfi CA; Croghan TW; Kniesner TJ; Obenchain RL J Ment Health Policy Econ; 2000 Dec; 3(4):187-197. PubMed ID: 11967455 [TBL] [Abstract][Full Text] [Related]
3. Prefrontal cortex activation during neuropsychological tasks might predict response to pharmacotherapy in patients with obsessive-compulsive disorder. Takeda T; Sumitani S; Hamatani S; Yokose Y; Shikata M; Ohmori T Neuropsychiatr Dis Treat; 2017; 13():577-583. PubMed ID: 28260905 [TBL] [Abstract][Full Text] [Related]
4. The SSRIs: advantages, disadvantages and differences. Lane R; Baldwin D; Preskorn S J Psychopharmacol; 1995 Jan; 9(2 Suppl):163-78. PubMed ID: 22297235 [TBL] [Abstract][Full Text] [Related]
5. Healthcare utilization and costs in patients beginning pharmacotherapy for generalized anxiety disorder: a retrospective cohort study. Berger A; Edelsberg J; Bollu V; Alvir JM; Dugar A; Joshi AV; Oster G BMC Psychiatry; 2011 Dec; 11():193. PubMed ID: 22151689 [TBL] [Abstract][Full Text] [Related]
6. Evidence-based pharmacotherapy of panic disorder. Bakker A; van Balkom AJ; Stein DJ Int J Neuropsychopharmacol; 2005 Sep; 8(3):473-82. PubMed ID: 15804373 [TBL] [Abstract][Full Text] [Related]
7. [Antidepressant pharmacotherapy: a review of pharmaco-economic research]. Sclar DA; Pharm B; Skaer TL; Pharm D; Robinson LM Encephale; 1999; 25(5):373-80. PubMed ID: 10598299 [TBL] [Abstract][Full Text] [Related]
8. Paroxetine and congenital malformations: meta-Analysis and consideration of potential confounding factors. Bar-Oz B; Einarson T; Einarson A; Boskovic R; O'Brien L; Malm H; Bérard A; Koren G Clin Ther; 2007 May; 29(5):918-926. PubMed ID: 17697910 [TBL] [Abstract][Full Text] [Related]
9. Current and Emerging Treatments for Premature Ejaculation. McMahon CG Sex Med Rev; 2015 Jul; 3(3):183-202. PubMed ID: 27784609 [TBL] [Abstract][Full Text] [Related]
11. Neonatal Outcomes in Maternal Depression in Relation to Intrauterine Drug Exposure. Corti S; Pileri P; Mazzocco MI; Mandò C; Moscatiello AF; Cattaneo D; Cheli S; Baldelli S; Pogliani L; Clementi E; Cetin I Front Pediatr; 2019; 7():309. PubMed ID: 31403037 [No Abstract] [Full Text] [Related]
12. Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques. Bies RR; Gastonguay MR; Coley KC; Kroboth PD; Pollock BG Am J Geriatr Psychiatry; 2002; 10(6):696-705. PubMed ID: 12427578 [TBL] [Abstract][Full Text] [Related]
13. The Nordic health registers - an important source when evaluating the safety of antidepressants during pregnancy. Kieler H Clin Epidemiol; 2010 Oct; 2():205-7. PubMed ID: 21042552 [TBL] [Abstract][Full Text] [Related]
14. Sexual dysfunction in selective serotonin reuptake inhibitors (SSRIs) and potential solutions: A narrative literature review. Jing E; Straw-Wilson K Ment Health Clin; 2016 Jul; 6(4):191-196. PubMed ID: 29955469 [TBL] [Abstract][Full Text] [Related]
15. Self-mutilation and pharmacotherapy. Smith BD Psychiatry (Edgmont); 2005 Oct; 2(10):28-37. PubMed ID: 21120088 [TBL] [Abstract][Full Text] [Related]
16. Serotonergic drugs in the treatment of depressive and anxiety disorders. Den Boer JA; Bosker FJ; Slaap BR Hum Psychopharmacol; 2000 Jul; 15(5):315-336. PubMed ID: 12404310 [TBL] [Abstract][Full Text] [Related]
17. Pharmacotherapy for posttraumatic stress disorder. Stein DJ; Zungu-Dirwayi N; van Der Linden GJ ; Seedat S Cochrane Database Syst Rev; 2000; (4):CD002795. PubMed ID: 11034765 [TBL] [Abstract][Full Text] [Related]
18. Antidepressant pharmacotherapy: economic outcomes in a health maintenance organization. Sclar DA; Robison LM; Skaer TL; Legg RF; Nemec NL; Galin RS; Hughes TE; Buesching DP Clin Ther; 1994; 16(4):715-30; discussion 74. PubMed ID: 7982260 [TBL] [Abstract][Full Text] [Related]
19. Recent pharmacologic advances in antidepressant therapy. Kilts CD Am J Med; 1994 Dec; 97(6A):3S-12S. PubMed ID: 7992824 [TBL] [Abstract][Full Text] [Related]
20. Treatment with Selective Serotonin Reuptake Inhibitors in the Third Trimester of Pregnancy : Effects on the Infant. Nordeng H; Spigset O Drug Saf; 2005 Jul; 28(7):565-581. PubMed ID: 27722970 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]